Work

Drug evaluation: AP-23573--an mTOR inhibitor for the treatment of cancer.

Year: 2006

Type: article

Source: PubMed

Author: Laurie Elit

Institution: Juravinski Cancer Centre

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W85655972

FWCI: 0.563

Cites:

Cited by: 14

Related to: 10